28-May-2025 6:00 AM CST - Business Wire MindMed to Participate in June Investor Conferences $MNMD--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the Company or MindMed), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that members of the Companys management team will participate in the following investor conferences: Jefferies Global Healthcare Conference Format: Presentation Date and Time: Thursday, June 5, 2025 at 12:50 PM ET Location: New York, NY Webcast Link: Jefferies Glo
13-May-2025 6:00 AM CST - Business Wire MindMed to Present at the 2025 RBC Capital Markets Global Healthcare Conference Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the Company or MindMed), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that members of the Companys management team will present at the 2025 RBC Capital Markets Global Healthcare Conference: 2025 RBC Capital Markets Global Healthcare Conference Format: Fireside Chat and 1x1 Meetings Date: May 21, 2025, at 2:05 PM ET Location: New Yor
8-May-2025 6:00 AM CST - Business Wire MindMed Reports First Quarter 2025 Financial Results and Recent Business Updates $MNMD--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced its first quarter 2025 financial results and provided an update on business highlights. We are proud to share that all three of our pivotal Phase 3 trials evaluating MM120 ODT in patients with GAD and MDDVoyage, Panorama, and Emergeare actively enrolling. Momen
24-Apr-2025 6:00 AM CST - Business Wire MindMed to Report First Quarter 2025 Financial Results on May 8, 2025 Mind Medicine (MindMed) Inc. (Nasdaq: MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that it will host a live webcast at 8:00 a.m. ET on Thursday, May 8, 2025 to report financial results for the first quarter ended March 31, 2025, and discuss recent business updates. Listeners can register for the webcast via this link. Analysts wishing to partici
6-Mar-2025 6:00 AM CST - Business Wire MindMed Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Updates Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced its fourth quarter and full year 2024 financial results and provided an update on business highlights. 2024 was a year of significant progress for MindMed. We successfully achieved several key milestones that have built momentum for multiple clinical readouts fro
4-Mar-2025 6:00 AM CST - Business Wire MindMed to Present at Leerinks Global Healthcare Conference 2025 Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the Company or MindMed), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that members of the Companys management team will present at Leerinks Global Healthcare Conference: Leerinks Global Healthcare Conference Format: Fireside Chat and 1x1 Meetings Date: March 11, 2025 at 3:40 PM ET Location: Miami Beach, FL Webcast Link: Leerinks
20-Feb-2025 6:00 AM CST - Business Wire MindMed to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025 Mind Medicine (MindMed) Inc. (Nasdaq: MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that it will host a live webcast at 8:00 a.m. ET on Thursday, March 6, 2025 to report financial results for the fourth quarter and year ended December 31, 2024, and discuss recent business updates. Listeners can register for the webcast via this link. Analysts wis
4-Feb-2025 6:00 AM CST - Business Wire MindMed to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the Company or MindMed), a late-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that members of the Companys management team will present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference: Oppenheimer 35th Annual Healthcare Life Sciences Conference Format: Fireside Chat and 1x1 Meetings Date: February 12, 2025 at 9:20 AM ET Location:
13-Nov-2024 6:00 AM CST - Business Wire MindMed to Participate in Upcoming Investor Conferences Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the Company or MindMed), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that members of the Companys management team will participate in the following investor conferences: Jefferies London Healthcare Conference Format: 1x1 Meetings Dates: November 20-21, 2024 Location: London, UK 7th Annual Evercore HealthCONx Conference Format: Fireside
28-May-2025 6:00 AM CST - Business Wire MindMed to Participate in June Investor Conferences $MNMD--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the Company or MindMed), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that members of the Companys management team will participate in the following investor conferences: Jefferies Global Healthcare Conference Format: Presentation Date and Time: Thursday, June 5, 2025 at 12:50 PM ET Location: New York, NY Webcast Link: Jefferies Glo
13-May-2025 6:00 AM CST - Business Wire MindMed to Present at the 2025 RBC Capital Markets Global Healthcare Conference Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the Company or MindMed), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that members of the Companys management team will present at the 2025 RBC Capital Markets Global Healthcare Conference: 2025 RBC Capital Markets Global Healthcare Conference Format: Fireside Chat and 1x1 Meetings Date: May 21, 2025, at 2:05 PM ET Location: New Yor
8-May-2025 6:00 AM CST - Business Wire MindMed Reports First Quarter 2025 Financial Results and Recent Business Updates $MNMD--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced its first quarter 2025 financial results and provided an update on business highlights. We are proud to share that all three of our pivotal Phase 3 trials evaluating MM120 ODT in patients with GAD and MDDVoyage, Panorama, and Emergeare actively enrolling. Momen
24-Apr-2025 6:00 AM CST - Business Wire MindMed to Report First Quarter 2025 Financial Results on May 8, 2025 Mind Medicine (MindMed) Inc. (Nasdaq: MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that it will host a live webcast at 8:00 a.m. ET on Thursday, May 8, 2025 to report financial results for the first quarter ended March 31, 2025, and discuss recent business updates. Listeners can register for the webcast via this link. Analysts wishing to partici
6-Mar-2025 6:00 AM CST - Business Wire MindMed Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Updates Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced its fourth quarter and full year 2024 financial results and provided an update on business highlights. 2024 was a year of significant progress for MindMed. We successfully achieved several key milestones that have built momentum for multiple clinical readouts fro
4-Mar-2025 6:00 AM CST - Business Wire MindMed to Present at Leerinks Global Healthcare Conference 2025 Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the Company or MindMed), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that members of the Companys management team will present at Leerinks Global Healthcare Conference: Leerinks Global Healthcare Conference Format: Fireside Chat and 1x1 Meetings Date: March 11, 2025 at 3:40 PM ET Location: Miami Beach, FL Webcast Link: Leerinks
20-Feb-2025 6:00 AM CST - Business Wire MindMed to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025 Mind Medicine (MindMed) Inc. (Nasdaq: MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that it will host a live webcast at 8:00 a.m. ET on Thursday, March 6, 2025 to report financial results for the fourth quarter and year ended December 31, 2024, and discuss recent business updates. Listeners can register for the webcast via this link. Analysts wis
4-Feb-2025 6:00 AM CST - Business Wire MindMed to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the Company or MindMed), a late-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that members of the Companys management team will present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference: Oppenheimer 35th Annual Healthcare Life Sciences Conference Format: Fireside Chat and 1x1 Meetings Date: February 12, 2025 at 9:20 AM ET Location:
13-Nov-2024 6:00 AM CST - Business Wire MindMed to Participate in Upcoming Investor Conferences Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the Company or MindMed), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that members of the Companys management team will participate in the following investor conferences: Jefferies London Healthcare Conference Format: 1x1 Meetings Dates: November 20-21, 2024 Location: London, UK 7th Annual Evercore HealthCONx Conference Format: Fireside
